Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Filter results
You can narrow down the results using the filters
Topic
- Alert/Advisory (1066)
- Medicines safety (465)
- Medical devices safety (326)
- Medicines (56)
- Shortages (34)
- Safety (13)
- Prescription medicines (10)
- Blood safety (8)
- Medical devices (8)
- Unapproved therapeutic goods (5)
- Listed medicines (4)
- Advertising (2)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Import and export (2)
- Legislation (2)
- Over the counter medicine (2)
- Regulatory compliance (2)
- Biologicals (1)
- Breast implant hub (1)
- Clinical trials (1)
- Complementary medicines (1)
- Labelling and packaging (1)
- Non-prescription medicines (1)
- Therapeutic goods regulation (1)
Search
1217 result(s) found, displaying 126 to 150
- Safety alertsResurrection Male Sexual Enhancement CapsulesResurrection Male Sexual Enhancement capsules pose a serious risk to your health and should not be taken.
- Safety alertsPregabalin and gabapentinSafety advisory - enhanced warnings relating to abuse and dependence
- Medicine shortage alertsErgometrine maleate injection (500 microgram/mL) ampouleAlternative product approved to address expected shortage
- Safety alertsMedicines containing Eucommia ulmoides (known as Du-Zhong or Tu-chung)Safety advisory – contains latex (statement includes Chinese translation 中文翻译)
- Product recallsTenofovir Disoproxil Emtricitabine Mylan 300/200Recall - potential for split tablets to lead to ineffective dose
- Medicine shortage alertsShortage of Estradot (estradiol) 25 and 75The TGA is extending the Serious Shortage Substitution Notice (SSSN) for Estradot 25 and issuing a new SSSN for Estradot 75
- Safety alertsUse of face masks during MRI examinationsPatients may be injured if they wear face masks (such as surgical or non-surgical masks and respirators) with metal parts and coatings during an MRI examination
- Safety alertsAntidepressant utilisation and risk of suicide in young peopleSafety investigation in response to concerns that increased antidepressant prescribing had resulted in an increased rate of suicide in young people in Australia
- Medicine shortage alertsTranylcypromine (Parnate)Extension of Tranylcypromine (Parnate) shortage until 31 January 2021
- Safety alertsPotential contamination of Australian metformin medicinesLow levels of contamination with N-nitrosodimethylamine (NDMA)
- Safety alertsGrain German Shepherd tabletsGrain German Shepherd tablets pose a serious risk to your health and should not be taken.
- Safety alertsRise 2.0 Liquid Cialis 30ml bottle(s)Rise 2.0 Liquid Cialis 30ml bottles pose a serious risk to your health and should not be taken.
- Safety alertsINFINITY 10K capsulesINFINITY 10K capsules pose a serious risk to your health and should not be taken
- Safety alertsBEAST Natural Formula 41,000 MG capsulesBEAST Natural Formula 41,000 MG capsules pose a serious risk to your health and should not be taken
- Safety alertsH.R.D. TabletsH.R.D. Tablets pose a serious risk to your health and should not be taken
- Safety alertsKANGAROO 2019 Mega 3000 tabletsKANGAROO 2019 Mega 3000 tablets pose a serious risk to your health and should not be taken
- Safety alertsSCORPION Natural Formula 41,000 MG capsulesSCORPION Natural Formula 41,000 MG capsules pose a serious risk to your health and should not be taken
- Safety alertsListed medicines containing Artemisia speciesSafety advisory - potential risk during pregnancy
- Medicine shortage alertsShortage of Brevinor and Norimin (ethinylestradiol/norethisterone)Update - Alternative products approved to address shortages
- Medicine shortage alertsPhenelzine (Nardil)Alternative product approved to address discontinuation
- Medicine shortage alertsTranylcypromine (Parnate) shortage - alternative product approvedAlternative product approved to address expected shortage